Blog / Archives
Risk Appetite Returns To Biotech With IBB Up Over 3%
Rayno Life Science Stocks -Green Screen Rules-NASDAQ (4168) Up 1.16% Speculative ETF XBI (134.50) up 4.69% and 7.88% over 5 days; 52 week high $172.52. ETF PBE ($40.85) up over 3%. Momentum stocks...
Another Green Day For Biotech- Rayno Life Science Movers: ALKS, BIIB, GILD, ILMN, RGDX
Biotech Stocks Have A Strong Day-April 15 Bottom Holding Rayno Life Science Portfolios Stick with larger caps through earnings: ABBV, AMGN, ALKS, BIIB, GILD. MOMO mid cap stocks coming back today:...
Tradable Bottom In With Biotech But Don’t Go Crazy
Large Caps Are Recovering But Follow Q1 Earnings Closely Fidelity Select Biotech FBIOX( $176 ) must hold $172 for new buys. Healthcare sector XLV ($56.94) lagging industrials and energy. April 15...
No Confirmed Trading Bottom In Biotech Yet: Biotech ETF Review..Update-1
Update at Close 4/15….. Late Day Reversal To Green The NASDAQ Composite began a rally at 1P EDT and never stopped , moving up 62 points to close at 4034. Biotech ETFs followed step by step to end up...
Biotech Rout Not Surprising: Surveying The Damage
Top Ten Reasons For Biotech Correction NASDAQ at 4022,IBB at 221 A Sentiment Driven Market We have been writing about the bull market in biotech stocks since its inception in March 2009 when quality...
Risk Reversal: Bargain Hunting and FOMC Catalyst Perks Up Biotech Stocks… Update-1
Update 4/10 Abrupt Sell-Off --Failure to Confirm Bottom NASDAQ down 71 pts 1.7% All of yesterdays' gains wiped out and we are back to January levels. Raise cash levels to 30% on life science...
Seeking A Technical Bottom For Biotech Stocks….. Update 4/9 Rally
NASDAQ Up 0.37% to 4133 Green screen alert with large cap biotechs. Time to cover hedges. Alexion (ALXN) up 2.23% Biogen (BIIB) Up 2.4% Celgene (CELG) up 3.61% Clovis Oncology (CLVS) up 2.85% Gilead...
Rayno Life Science: Tools and Diagnostics Q1 2014 Performance
Caution As Life Science Stocks Are Consolidating Life science stocks had a wild roller coaster ride in 2014 with many stocks peaking around March 1. Momentum and cult stocks in our portfolio still...
Biotech Sell-Off Resumes: Caution Update 4/4
Update 4/4/14 Breach of Technicals-A Tad Below Early February Support Glut of Biotech IPOs Causing Indigestion? Momentum Days Are So Over NASDAQ Down 1.34% The volatile and speculative SPDR S&P...
Rayno Biopharmaceutical Stocks Q1 2014 Performance
Rayno Biopharmaceutical Portfolio 3/31/14 Most of our biotech picks did well in a tough quarter that went through a severe correction in early February and again in late March. Many small and...